This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Vapotherm Ausschüttungen und Rückkäufe

Zukünftiges Wachstum Kriterienprüfungen 0/6

Vapotherm hat in der Vergangenheit keine Dividende gezahlt.

Wichtige Informationen

n/a

Dividendenausschüttung

-0.2%

Rückkaufsrendite

Gesamte Aktionärsrendite	-0.2%
Zukünftige Dividendenrendite	n/a
Wachstum der Dividende	n/a
Nächster Dividendenzahlungstermin	n/a
Ex-Dividendendatum	n/a
Dividende pro Aktie	n/a
Ausschüttungsquote	n/a

Jüngste Updates zu Dividenden und Rückkäufen

Keine Aktualisierungen

Recent updates

Vapotherm announces $23M private placement

Feb 08

Vapotherm GAAP EPS of -$0.98 misses by $0.20, revenue of $13.5M misses by $3.02M

Nov 02

The Independent Director of Vapotherm, Inc. (NYSE:VAPO), Anthony Arnerich, Just Bought 59% More Shares

Mar 12

Announcing: Vapotherm (NYSE:VAPO) Stock Increased An Energizing 225% In The Last Year

Mar 11

Does Vapotherm (NYSE:VAPO) Have A Healthy Balance Sheet?

Jan 19

Vapotherm guides Q4 revenue above consensus, ~212% Y/Y growth

Jan 13

Thomas Smith of Vapotherm, Inc. (NYSE:VAPO) Just Spent US$217k On Shares

Dec 14

Investors Who Bought Vapotherm (NYSE:VAPO) Shares A Year Ago Are Now Up 132%

Dec 11

Vapotherm shares +9% on higher Q4 guidance

Dec 01

Vapotherm: The Game Has Completely Changed

Nov 13

Stabilität und Wachstum des Zahlungsverkehrs

Rufe Dividendendaten ab

Stabile Dividende: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Dividende je Aktie von VAPO in der Vergangenheit stabil war.

Wachsende Dividende: Unzureichende Daten, um festzustellen, ob die Dividendenzahlungen von VAPO gestiegen sind.

Dividendenrendite im Vergleich zum Markt

Vapotherm Dividendenrendite im Vergleich zum Markt

Wie sieht die Dividendenrendite von VAPO im Vergleich zum Markt aus?
Segment	Dividendenrendite
Unternehmen (VAPO)	n/a
Untere 25 % des Marktes (US)	1.3%
Markt Top 25 % (US)	4.2%
Branchendurchschnitt (Medical Equipment)	1.6%
Analystenprognose (VAPO) (bis zu 3 Jahre)	n/a

Bemerkenswerte Dividende: Es ist nicht möglich, die Dividendenrendite von VAPO im Vergleich zu den unteren 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.

Hohe Dividende: Es ist nicht möglich, die Dividendenrendite von VAPO im Vergleich zu den besten 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.

Gewinnausschüttung an die Aktionäre

Abdeckung der Erträge: Unzureichende Daten zur Berechnung der Ausschüttungsquote von VAPO, um festzustellen, ob die Dividendenzahlungen durch die Gewinne gedeckt sind.

Barausschüttung an die Aktionäre

Cashflow-Deckung: Es ist nicht möglich, die Nachhaltigkeit der Dividende zu berechnen, da VAPO keine Ausschüttungen gemeldet hat.

This company has been acquired

Vapotherm Ausschüttungen und Rückkäufe

Zukünftiges Wachstum Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Updates zu Dividenden und Rückkäufen

Recent updates

Perceptive Discovery Fund LP, managed by Perceptive Advisors LLC completed the acquisition of Vapotherm, Inc. (OTCPK:VAPO) from a group of shareholders.

Perceptive Discovery Fund LP, managed by Perceptive Advisors LLC entered into definitive merger agreement to acquire Vapotherm, Inc. (OTCPK:VAPO) for $15.1 million.

Vapotherm, Inc. to Unveil Access365 Home Ventilation Solution at MEDTRADE

The New York Stock Exchange to Commence Delisting Proceedings against Vapotherm

Vapotherm, Inc. Revises Revenue Guidance for the Full Year 2023

Vapotherm, Inc. to Report Q3, 2023 Results on Nov 08, 2023

Vapotherm Announces Presentation of an Investigator-Initiated Clinical Trial, 'High Flow Humidified Oxygen as an Early Intervention in Children with Acute Severe Asthma - a Feasibility Randomized Controlled Trial' at the European Respiratory Society International Congress 2023

Vapotherm, Inc. Revises Earnings Guidance for Fiscal 2023

Vapotherm, Inc. to Report Q2, 2023 Results on Aug 08, 2023

Vapotherm, Inc. Reports Impairment of Long-Lived and Intangible Assets for the First Quarter Ended March 31, 2023

Vapotherm Receives Price Cure Notification Letter from the NYSE Indicates its Stock Price Above the NYSE's Minimum Requirement

Vapotherm, Inc. to Report Q4, 2022 Results on Feb 23, 2023

Vapotherm announces $23M private placement

Vapotherm, Inc. Provides Revenue Guidance for the Fourth Quarter of 2022

Vapotherm, Inc. Provides Revenue Guidance for 2022

Vapotherm GAAP EPS of -$0.98 misses by $0.20, revenue of $13.5M misses by $3.02M

Vapotherm, Inc. to Report Q3, 2022 Results on Nov 02, 2022

Vapotherm Announces NYSE Continued Listing Standard Notice

Vapotherm draws downgrade at William Blair after 2Q results

Vapotherm, Inc. Reports Unaudited Condensed Consolidated Impairment Charges for the Second Quarter Ended June 30, 2022

Vapotherm, Inc. to Report Q2, 2022 Results on Aug 03, 2022

Vapotherm, Inc. Plans to Move All of Its Manufacturing Operations from New Hampshire to Mexico

Price target decreased to US$4.83

Vapotherm, Inc.(NYSE:VAPO) dropped from Russell 2000 Growth Index

Vapotherm: Out Of Air

Vapotherm, Inc. Revises Earnings Guidance for the Fiscal Year 2022

Vapotherm, Inc., Annual General Meeting, Jun 21, 2022

Vapotherm, Inc. Provides Revenue Guidance for the First Quarter of 2022

Consensus forecasts updated

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Price target decreased to US$34.33

Vapotherm, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year 2022

Vapotherm, Inc. to Report Q4, 2021 Results on Feb 24, 2022

Is Vapotherm (NYSE:VAPO) Using Too Much Debt?

Vapotherm, Inc. Announces Revenue Guidance for the Fourth Quarter of 2021, Full Year 2021 and 2022

Third quarter 2021 earnings released: US$0.52 loss per share (vs US$0.49 loss in 3Q 2020)

Chief Accounting Officer Joel Dube has left the company

Vapotherm, Inc. Revises Revenue Guidance for the Fiscal Year 2021

Vapotherm, Inc. Announces FDA 510(k) Clearance for HVT 2.0 Next Generation Platform

Senior VP notifies of intention to sell stock

Second quarter 2021 earnings released: US$0.67 loss per share (vs US$0.35 loss in 2Q 2020)

Senior VP & Chief Commercial Officer exercised options and sold US$170k worth of stock

Vapotherm: Hardly Breathing Room

Insider recently bought US$4.8m worth of stock

Independent Director Marina Hahn has left the company

Independent Chairman of the Board recently bought US$170k worth of stock

Health Check: How Prudently Does Vapotherm (NYSE:VAPO) Use Debt?

First quarter 2021 earnings released: US$0.40 loss per share (vs US$0.66 loss in 1Q 2020)

Vapotherm, Inc. Provides Financial Guidance for 2021

Vapotherm reports Q1 results

The Independent Director of Vapotherm, Inc. (NYSE:VAPO), Anthony Arnerich, Just Bought 59% More Shares

Independent Director recently bought US$109k worth of stock

Announcing: Vapotherm (NYSE:VAPO) Stock Increased An Energizing 225% In The Last Year

Full year 2020 earnings released: US$2.16 loss per share (vs US$2.74 loss in FY 2019)

Revenue and earnings beat expectations

New 90-day low: US$23.17

Vapotherm, Inc. to Report Q4, 2020 Results on Feb 24, 2021

Senior VP & Chief Commercial Officer notifies of intention to sell stock

Senior VP & Chief Commercial Officer exercised options and sold US$56k worth of stock

Does Vapotherm (NYSE:VAPO) Have A Healthy Balance Sheet?

Vapotherm guides Q4 revenue above consensus, ~212% Y/Y growth

New 90-day high: US$32.08

Thomas Smith of Vapotherm, Inc. (NYSE:VAPO) Just Spent US$217k On Shares

Insider recently bought US$217k worth of stock

Investors Who Bought Vapotherm (NYSE:VAPO) Shares A Year Ago Are Now Up 132%

Analysts update estimates

Vapotherm, Inc. Revises Revenue Guidance for the Fourth Quarter and Full Year 2020

Vapotherm shares +9% on higher Q4 guidance

Vapotherm: The Game Has Completely Changed

New 90-day low: US$23.44

Revenue beats expectations, earnings disappoint

Third quarter 2020 earnings released: US$0.49 loss per share

Price target lowered to US$42.67

Vapotherm, Inc. Not Provides Earnings Guidance for the Full Year 2020